PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsLCL161
LCL161
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
10 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Triple negative breast neoplasmsD064726——11———2
Multiple myelomaD009101—C90.011———2
Plasma cell neoplasmsD054219——11———2
Myeloproliferative disordersD009196—D47.1—1———1
Essential thrombocythemiaD013920—D47.3—1———1
Polycythemia veraD011087—D45—1———1
Primary myelofibrosisD055728—D47.4—1———1
ThrombocytosisD013922HP_0001894D75.83—1———1
PolycythemiaD011086EFO_0005804D75.1—1———1
Breast neoplasmsD001943EFO_0003869C50—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369—C803————3
Renal cell carcinomaD002292EFO_0000376—1————1
Non-small-cell lung carcinomaD002289——1————1
Kidney neoplasmsD007680EFO_0003865C641————1
Ovarian neoplasmsD010051EFO_0003893C561————1
Lung neoplasmsD008175HP_0100526C34.901————1
Small cell lung carcinomaD055752——1————1
Pancreatic neoplasmsD010190EFO_0003860C251————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use